China Resources Pharmaceutical Group raised HK$14 billion ($1.8 billion) from Hong Kong’s second biggest initial public offering this year, pricing the share sale near the bottom end of the guidance before trading opened on Friday.
¬ Haymarket Media Limited. All rights reserved.
